The NOD mouse is an established model of autoimmune diabetes mellitus. Various lines of NOD mice differ in their incidence of spontaneous diabetes, e.g. 93% of female NOD/Lt mice compared with 46% of female NOD/Wehi mice develop diabetes by 250 days. These two lines were studied under conditions which greatly accelerate the onset of hyperglycaemia. It was hoped that their responses to these manipulations would reveal characteristic differences which would increase our understanding of diabetes resistance in the low incidence NOD/Wehi line. One dose of 300 mg/kg of cyclophosphamide (CP) produced hyperglycaemia in 50% of NOD mice within 2 weeks in both lines. They were also equally susceptible to diabetes induced by splenocyte transfer at 21 days of age from prediabetic 150-day-old NOD/Lt or NOD/Wehi females. Five daily 40 mg/kg doses of streptozotocin (STZ) resulted in a severity of diabetes in the NOD mice greater than in C57BL or SJL/J mice. While the incidence and severity of diabetes induced in the two NOD lines were similar, this appeared to be principally due to sensitivity to the toxic effects of STZ rather than its ability to exacerbate autoimmune # cell destruction. It has previously been shown that it is possible to prevent diabetes in susceptible NOD mice with simple, relatively benign therapies and here we show that it is possible to induce diabetes in resistant animals at a rate indistinguishable from fully predisposed individuals. It therefore appears that the prediabetic NOD mouse is poised in an immunologically precarious state with the onset of disease being highly dependent on factors which exacerbate or moderate autoimmune destruction.
INTRODUCTION
NOD mice were derived from a single diabetic female JCL: ICR outbred mouse which was found to be of low weight, polyuric, polydipsic and glycosuric (Makino et al., 1980) . Since their description in 1980, many colonies have been established throughout the world, and maintained in separate breeding programmes. In addition to this potential genetic heterogeneity, NOD mice are profoundly affected by environmental variables such as diet (Elliott, et al., 1988; Scott, Daneman & Martin, 1988; Coleman, Kuzava & Leiter 1990 ) and exposure to pathogens (Oldstone, 1988; Leiter, 1990) . As a result, the incidence of diabetes in different lines varies greatly (Colony Information Sheets, 1989) . Two such lines are maintained in the same environment at the Walter and Eliza Hall Institute (WEHI) (Baxter, Adams & Mandel, 1989 Australia. cell transfer comparative immunology comparison of immunological parameters mediating the relative resistance to diabetes in the lower incidence line.
The NOD/Lt line maintains a consistently high incidence of diabetes in females at 250 days (93%), while the NOD/Wehi females become diabetic less frequently (43%). Both lines express a much lower incidence of disease in males (21 I/O versus 6%). Histological examination of islets reveals significantly more severe mononuclear cell infiltration in the high incidence (NOD/Lt) line. This supports our premise that the difference in diabetes incidence results from differences in the severity of autoimmune destruction occurring in the two lines (Baxter, Koulmanda & Mandel, 1991 Histological assessment of insulitis Pancreata were fixed in Bouins' fixative, transferred to alcohol, paraffin embedded and sectioned at three levels. Slides were stained with haematoxylin and eosin or Gomori aldehyde fuchsin, and independently scored by two observers as previously described (Baxter et al., 1991) . Briefly, a semi-objective score from 0 to 4 was assigned to each islet. A score of 0 indicated an islet free of pathology, and a score of 4 indicated virtually complete destruction. The scores were then totalled and expressed as a percentage of the total possible score. Age (days) Fig. 1 . Female weanlings 21 days old were injected with 2-0 x 10 splenocytes from 150-day-old non-diabetic female NOD/Lt mice. Mice were bled 2-weekly and the onset of diabetes was defined as a serum glucose estimation in excess of 12-0 mmol/l followed by either further raised estimations or rapid demise. Yates' correction, Table 2 ). There was no significant difference in the intensity of lymphocytic infiltrate in the pancreata of the experimental groups (Kruskal-Wallis test). Larger numbers of splenocytes injected did not further accelerate disease onset as the injection of 2-0 x 107 NOD/Lt splenocytes together with 2-0 x 107 NOD/Wehi splenocytes resulted in the same proportion of diabetic mice as NOD/Lt 150 splenocytes alone (data not shown).
Low dose streptozotocin Six NOD/Lt, six C57BL/KaWehi and six C57BL/6JWehi 9-week-old male mice were injected daily for 5 days with STZ and bled at 5-day intervals for 30 days. All mice except one C57BL/ KaWehi mouse became diabetic. The serum glucose was significantly higher in Ohe NOD/Lt mice than either the SJL/ JWehi (P < 0-005) or the C57BL/KaWehi (P < 0-002, rank sum test) mice. Lymphocytic infiltration and ,B cell destruction was greatest in the NOD/Lt mice and least in the C57BL/KaWehi mice (data not shown). Six NOD/Lt, six C57BL/6JWehi and six SJL/JWehi 9-weekold female mice were treated similarly. Three NOD/Lt and four SJL/JWehi mice became mildly diabetic while no C57BL/ 6JWehi mice did (not significant, Fisher's test). The serum glucose levels of NOD/Lt (9-2-21-8, mean 14-2 mmol/l) and SJL/JWehi (9-5-13 6, mean 13-1 mmol/l) mice were not significantly different from each other but were from C57BL/6JWehi (5-7-11-8, mean 9-7 mmol//) mice (P < 0-05, rank sum test).
Twenty-four NOD/Wehi and 23 NOD/Lt male 9-week-old mice were weighed and bled before multiple low dose STZ treatment. There was no significant difference between the weights or pretreatment serum glucose estimations (Student's ttest). All NOD/Wehi mice and 19 out of 23 NOD/Lt mice became diabetic (P < 0-05, x2 test), but this is not likely to be of real significance as the distribution of serum glucose estimations in both groups was similar and bimodal (Fig. 2) . Eight of 24 NOD/Wehi and 9 out of 23 NOD/Lt mice fell into a 'low responding' group with serum glucoses ranging from 9 4 to 25-0 mmol/l. The remainder were 'high responders', with the majority having serum glucose estimations in excess of 40-0 mmol/l. There was no significant difference in the severity of hyperglycaemia between the two lines (rank sum test). Serum glucose (mmol/1) Fig. 2 (Yasunami & Bach, 1988; Charlton et al., 1989) was also effective, and the proportion of animals rendered diabetic appeared to be dose-dependent (Charlton et al., 1989) . Splenocytes from animals rendered diabetic in this manner were able to transfer disease to naive recipients, indicating the mechanism of action was not # cell toxicity (Yasunami & Bach, 1988) . Animals injected with CP could be 'rescued' from diabetes onset by multiple early injections of spleen and lymph node cells, suggesting that the acceleration of diabetes resulted from an imbalance in a lymphoid compartment (Charlton et al., 1989) . This imbalance has been postulated to be a selective depletion of cells which mediate immunological suppression, as CP has a similar action in the induction of experimental allergic encephalomyelitis (Lando, Teitelbaum & Arnon, 1980) and autoimmune diabetes induced by multiple low dose STZ (Keisel et al., 1981) .
Here we have shown the NOD/Wehi and NOD/Lt lines were equally susceptible to CP-precipitated diabetes despite differing in their incidence of spontaneous disease. If the action of CP in this model is the selective depletion of suppression, this result can be explained by supposing an increased level of suppression in the NOD/Wehi line which normally reduces the incidence of diabetes, but which is eradicated by CP treatment.
Acceleration of diabetes by splenocyte injection has been studied in detail by several groups. Splenic T cells from NOD mice respond to islet antigens in vitro by proliferation and the production of IL-2. This response is first seen in 50-day-old mice, and is maximal at 150 days (Nagata et al., 1989) .
Splenocytes from overtly diabetic NOD mice can transfer diabetes to irradiated adult (Wicker, Miller & Mullen, 1986) or unirradiated neonatal (Bendelac et al., 1987) syngeneic mice. This property is also found in the splenocytes of non-diabetic NOD mice older than 50 days, and is maximal in female mice older than 130 days (Bendelac et al., 1987) , appearing to parallel in vitro reactivity to islets. Disease transfer is dependent on recipient and donor age and sex, and the number of cells transferred.
It was hoped that this model would allow differentiation between the activity of autoreactive T cells present in the splenocyte inoculum and the resistance to transfer in the recipient. The finding that both lines were equally susceptible to induction of diabetes by NOD/Lt splenocytes suggested that NOD/Wehi mice do not have a stronger 'suppressor' of immune destruction than NOD/Lt mice, but rather that they simply undergo a less vigorous autoimmune activation. However, this hypothesis must also be discarded in view of the finding that NOD/Wehi splenocytes were equally capable of transferring disease. Thus, it is unlikely that the model suggested by Reich et al. (1989a Reich et al. ( , 1989b of two opposing populations of lymphocytes, one autoaggressive and the other regulatory, provides a satisfactory explanation for the processes involved in this model.
STZ is a broad spectrum antibiotic with diabetogenic properties mediated by direct fi cell cytotoxicity (Rakieten, Rakieten & Nadkarni, 1963 (Like & Rossini, 1976) . A regimen of six 35 mg/kg doses resulted in severe hyperglycaemia in males, but only moderate hyperglycaemia in females despite inducing a similar degree of lymphocytic infiltration. Furthermore, male athymic mice were also susceptible to severe hyperglycaemia despite the absence of an islet infiltrate (Leiter, 1982) . Thus diabetes induced by the multi-low dose STZ protocol appears to involve the dual action of incremental toxic destruction and the induction of autoimmunity to a fi cell neoantigen (reviewed in Kolb, 1987) . One possible source off, cell associated neoantigen is C-type retrovirus-like particles which were noted to be dramatically increased in the fl cells of STZ-treated mice (Like & Rossini, 1976) . Similar particles were seen in the cisternae of the rough endoplasmic reticulum of prediabetic NOD mice (FujinoKurihara et al., 1985) and were greatly increased following treatment with CP (Suenaga & Yoon, 1988) , suggesting a common, retroviral, autoantigen in all three models. Thus three possible mechanisms of JJ cell destruction potentially occur in the low dose STZ model: incremental toxicity, exposure and activation by novel STZ-induced antigen(s), and increased exposure to an existing, stimulatory autoantigen. The finding that it is unable to induce severe hyperglycaemia in female NOD/Lt mice suggests that the third mechanism does not play a role as there does not appear to be any evidence of a primed response in mice that were undergoing active autoimmune destruction of f, cells at the time of treatment. The two NOD lines appeared to be equally susceptible to both the toxic and autoimmune mechanisms.
It has previously been shown that it is possible to prevent diabetes in susceptible NOD mice by manipulation of environment (Williams et al., 1990) , diet (Elliott et al., 1988; Scott et al., 1988; Coleman et al., 1990 ) and exposure to pathogens (Oldstone, 1988; Leiter, 1990 ). Here we show that it is possible to induce diabetes in relatively resistant animals at a rate indistinguishable from fully predisposed individuals. These experiments throw little light on the mechanism of resistance to diabetes in the NOD/Wehi mice. While the CP data are consistent with an increased level of suppressor activity, the cell transfer experiments do not support this hypothesis. Paradoxically, the cell transfer experiments are not consistent with a less aggressive autoimmune attack either. The STZ experiments fail to resolve this problem, as the mechanism of action appears not to be related to the pre-existing autoimmune destruction occurring in the NOD. It is clear, however, that regardless of the mechanism of resistance in the NOD/Wehi line, it is easily overcome by experimental manipulation. It therefore appears that the prediabetic NOD mouse is poised in an immunologically precarious state with the onset of disease being highly dependent on factors which exacerbate or moderate autoimmune destruction.
